AngioDynamics up on FDA's breakthrough tag for heart device
** Shares of AngioDynamics ANGO.O rise 10.9% to $9.64
premarket
** Med tech firm says FDA has granted breakthrough
designation to co's heart device
** Breakthrough device designation helps patients gain
access to medical devices that may provide more effective
treatment for which no approved or cleared alternatives exist
** Up to Tuesday's close, stock was down ~37% YTD
(Reporting by Khushi Mandowara in Bengaluru)
((Khushi.Mandowara@thomsonreuters.com;))
Recent news on AngioDynamics
See all newsAngioDynamics, Inc. reports results for the quarter ended August 31 - Earnings Summary
AngioDynamics Q1 sales beat on med tech segment growth
AngioDynamics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
AngioDynamics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
AngioDynamics Inc reports results for the quarter ended May 31 - Earnings Summary